These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26689301)

  • 21. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging dogma: group A donors as "universal plasma" donors in massive transfusion protocols.
    Isaak EJ; Tchorz KM; Lang N; Kalal L; Slapak C; Khalife G; Smith D; McCarthy MC
    Immunohematology; 2011; 27(2):61-5. PubMed ID: 22356521
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood group genotyping: from patient to high-throughput donor screening.
    Veldhuisen B; van der Schoot CE; de Haas M
    Vox Sang; 2009 Oct; 97(3):198-206. PubMed ID: 19548962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Principles of transfusion medicine in small animals.
    Lanevschi A; Wardrop KJ
    Can Vet J; 2001 Jun; 42(6):447-54. PubMed ID: 11424576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [International databases: usefulness and limitations in hemovigilance].
    Wiersum-Osselton JC
    Transfus Clin Biol; 2010 Dec; 17(5-6):306-9. PubMed ID: 21055991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 29. The frequent and the unusual red cell phenotypes in Indian blood donors: A quest for rare donors.
    Setya D; Tiwari AK; Arora D; Mitra S; Mehta SP; Aggarwal G
    Transfus Apher Sci; 2020 Aug; 59(4):102765. PubMed ID: 32446634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Where to find a suitable red cell product, if the patient has a rare blood group?].
    Sareneva I; Ekblom-Kuliberg S; Haimila K; Korhonen A; Sainio S; Juvonen E
    Duodecim; 2015; 131(13-14):1248-53. PubMed ID: 26536721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DGTI Register of Rare Donors.
    Hustinx H
    Transfus Med Hemother; 2014 Oct; 41(5):338-41. PubMed ID: 25538534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping of 22 blood group antigen polymorphisms and establishing a national recipient registry in the Korean population.
    Hong YJ; Chung Y; Hwang SM; Park JS; Kwon JR; Choi YS; Kim JN; Lee DH; Kwon SY; Cho NS; Song EY; Park KU; Song J; Han KS
    Ann Hematol; 2016 May; 95(6):985-91. PubMed ID: 27021300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges of Establishing a National Rare Donor Program in Iran.
    Ghezelbash B; Moghaddam M; Aghazadeh S
    Int J Hematol Oncol Stem Cell Res; 2018 Jul; 12(3):213-219. PubMed ID: 30595824
    [No Abstract]   [Full Text] [Related]  

  • 34. Developing an administrative plan for transfusion medicine--a global perspective.
    Sullivan P
    Transfusion; 2005 Oct; 45(4 Suppl):224S-40S. PubMed ID: 16181405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor cycle and donor segmentation: new tools for improving blood donor management.
    Veldhuizen I; Folléa G; de Kort W
    Vox Sang; 2013 Jul; 105(1):28-37. PubMed ID: 23438134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of an immunoglobulin A-deficient blood donor registry with a simple in-house screening enzyme-linked immunosorbent assay.
    Thibault L; Beauséjour A; de Grandmont MJ; Long A; Goldman M; Chevrier MC
    Transfusion; 2006 Dec; 46(12):2115-21. PubMed ID: 17176323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries.
    Hurley CK; Raffoux C;
    Bone Marrow Transplant; 2004 Jul; 34(2):103-10. PubMed ID: 15170173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building a flexible, voluntary donation panel: an exploration of donor willingness.
    Bagot KL; Masser BM; Starfelt LC; White KM
    Transfusion; 2016 Jan; 56(1):186-94. PubMed ID: 26408074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.